Poking COVID-19: Insights on Genomic Constraints among Immune-Related Genes between Qatari and Italian Populations.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
22 11 2021
Historique:
received: 30 09 2021
revised: 10 11 2021
accepted: 12 11 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 15 12 2021
Statut: epublish

Résumé

Host genomic information, specifically genomic variations, may characterize susceptibility to disease and identify people with a higher risk of harm, leading to better targeting of care and vaccination. Italy was the epicentre for the spread of COVID-19 in Europe, the first country to go into a national lockdown and has one of the highest COVID-19 associated mortality rates. Qatar, on the other hand has a very low mortality rate. In this study, we compared whole-genome sequencing data of 14398 adults and Qatari-national to 925 Italian individuals. We also included in the comparison whole-exome sequence data from 189 Italian laboratory-confirmed COVID-19 cases. We focused our study on a curated list of 3619 candidate genes involved in innate immunity and host-pathogen interaction. Two population-gene metric scores, the Delta Singleton-Cohort variant score (DSC) and Sum Singleton-Cohort variant score (SSC), were applied to estimate the presence of selective constraints in the Qatari population and in the Italian cohorts. Results based on DSC and SSC metrics demonstrated a different selective pressure on three genes (MUC5AC, ABCA7, FLNA) between Qatari and Italian populations. This study highlighted the genetic differences between Qatari and Italian populations and identified a subset of genes involved in innate immunity and host-pathogen interaction.

Identifiants

pubmed: 34828448
pii: genes12111842
doi: 10.3390/genes12111842
pmc: PMC8623290
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Institute for Maternal and Child Health, IRCCS "Burlo Garofolo"
ID : 5X1000 funding
Organisme : Rome Foundation
ID : Italy, Prot 317A/I
Organisme : Regione Lazio
ID : Italy, Progetti di Gruppi di Ricerca 2020 A0375-2020-36663 GecoBiomark

Références

Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
Eur J Hum Genet. 2013 Jun;21(6):659-65
pubmed: 23249956
Cell Discov. 2020 Feb 24;6:11
pubmed: 32133153
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
BMJ Open. 2020 Oct 7;10(10):e040428
pubmed: 33033033
Am J Epidemiol. 2019 Aug 1;188(8):1420-1433
pubmed: 30927351
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Genet Med. 2020 Sep;22(9):1464-1466
pubmed: 32514089
Sci Rep. 2021 Mar 18;11(1):6233
pubmed: 33737535
Eur J Hum Genet. 2020 Jun;28(6):715-718
pubmed: 32404885
PLoS Biol. 2020 Nov 6;18(11):e3000970
pubmed: 33156843
Nat Commun. 2021 Oct 12;12(1):5929
pubmed: 34642339
Nat Commun. 2021 Feb 23;12(1):1250
pubmed: 33623009
Bioinformatics. 2010 Nov 15;26(22):2867-73
pubmed: 20926424
Virus Res. 2015 Apr 16;202:3-11
pubmed: 25481285
Genes (Basel). 2020 Aug 27;11(9):
pubmed: 32867305
N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
Trends Immunol. 2020 Nov;41(11):965-967
pubmed: 33023856
Front Cell Dev Biol. 2020 Oct 06;8:545089
pubmed: 33123533
PLoS Genet. 2013;9(8):e1003709
pubmed: 23990802
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Hum Genome Var. 2021 Apr 2;8:15
pubmed: 33824725
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Eur J Hum Genet. 2020 Apr;28(4):435-444
pubmed: 31784700
Sci Immunol. 2021 Aug 19;6(62):
pubmed: 34413140
BMC Infect Dis. 2020 Oct 19;20(1):777
pubmed: 33076848
Nature. 2021 Jul 8;:
pubmed: 34237774
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
J Cell Biol. 2006 Aug 14;174(4):547-56
pubmed: 16908670
J Med Virol. 2021 Feb;93(2):582-584
pubmed: 32776556
Emerg Infect Dis. 2021 May;27(5):1343-1352
pubmed: 33900174
Nat Genet. 2019 Nov;51(11):1560-1565
pubmed: 31676867
Nature. 2021 Mar;591(7848):92-98
pubmed: 33307546
Lancet. 2021 Feb 20;397(10275):671-681
pubmed: 33545094
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16528-33
pubmed: 23012413
Chest. 2021 Mar;159(3):e131-e135
pubmed: 33678279
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Protein Sci. 2021 Jan;30(1):187-200
pubmed: 33070389
J Lipid Res. 2006 Sep;47(9):1915-27
pubmed: 16788211
Hum Genet. 2020 May;139(5):647-655
pubmed: 32232557
Hum Genomics. 2021 Aug 25;15(1):57
pubmed: 34429158
IEEE/ACM Trans Comput Biol Bioinform. 2021 Jul-Aug;18(4):1271-1280
pubmed: 33891554
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246

Auteurs

Hamdi Mbarek (H)

Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha P.O. Box 5825, Qatar.

Massimiliano Cocca (M)

Institute for Maternal and Child Health, IRCCS 'Burlo Garofolo', 34137 Trieste, Italy.

Yasser Al-Sarraj (Y)

Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha P.O. Box 5825, Qatar.

Chadi Saad (C)

Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha P.O. Box 5825, Qatar.

Massimo Mezzavilla (M)

Institute for Maternal and Child Health, IRCCS 'Burlo Garofolo', 34137 Trieste, Italy.

Wadha AlMuftah (W)

Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha P.O. Box 5825, Qatar.

Dario Cocciadiferro (D)

Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

Antonio Novelli (A)

Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

Isabella Quinti (I)

Department of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.

Azza AlTawashi (A)

VP RDI Office, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha P.O. Box 5825, Qatar.

Salvino Salvaggio (S)

VP RDI Office, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha P.O. Box 5825, Qatar.

Asma AlThani (A)

Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha P.O. Box 5825, Qatar.

Giuseppe Novelli (G)

Department of Biomedicine and Prevention, Tor Vergata University of Rome, 00133 Rome, Italy.

Said I Ismail (SI)

Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha P.O. Box 5825, Qatar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH